These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1973396)

  • 41. [Pharmachem's salazopyrine in rheumatoid arthritis].
    Konstantinova M; Konstantinova V
    Vutr Boles; 1990; 29(5):65-8. PubMed ID: 1981958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulphasalazine and Delagil--a comparative study in patients with juvenile chronic arthritis.
    Hoza J; Kadlecová T; Nĕmcová D; Havelka S
    Acta Univ Carol Med (Praha); 1991; 37(1-2):80-3. PubMed ID: 1688268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Colebatch AN; Marks JL; Edwards CJ
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008872. PubMed ID: 22071858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drug treatment of rheumatoid arthritis and osteoarthritis].
    Trnavský K; Pavelka K
    Z Gesamte Inn Med; 1987 Aug; 42(15):434-6. PubMed ID: 2890243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of antirheumatic treatment on gastric secretory function and salivary flow in patients with rheumatoid arthritis.
    Kanerud L; Hafström I; Berg A
    Clin Exp Rheumatol; 1991; 9(6):595-601. PubMed ID: 1684921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.
    Montalto M; Curigliano V; Santoro L; Lombardi M; Covino M; Cammarota G; Dalvai S; D'Onofrio F; Gasbarrini A; Gasbarrini G
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):965-7. PubMed ID: 16894309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis.
    Tachecí I; Bradna P; Douda T; Baštecká D; Kopáčová M; Rejchrt S; Lutonský M; Soukup T; Bureš J
    Rheumatol Int; 2016 Nov; 36(11):1557-1561. PubMed ID: 27549792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489
    [No Abstract]   [Full Text] [Related]  

  • 51. A case of rheumatoid arthritis with protein losing enteropathy induced by multiple diaphragmatic strictures of the small intestine: successful treatment by bougieing under double-balloon enteroscopy.
    Kamata Y; Iwamoto M; Nara H; Kamimura T; Takayashiki N; Yamamoto H; Sugano K; Yoshio T; Okazaki H; Minota S
    Gut; 2006 Sep; 55(9):1372. PubMed ID: 16905713
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment with leflunomide in rheumatoid arthritis].
    Krüger K; Bolten W
    Z Rheumatol; 2005 Mar; 64(2):96-101. PubMed ID: 15793675
    [No Abstract]   [Full Text] [Related]  

  • 54. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of 5-aminosalicylic acid as a constituent of sulfasalazine in the treatment of chronic polyarthritis].
    Wörth WD; Müller W
    Z Rheumatol; 1986; 45(2):79-82. PubMed ID: 2873695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Association between AIF-1 gene polymorphisms and response to rheumatoid arthritis treatment with sulphasalazine].
    Dabrowska-Zamojcin E; Herczyńska MM; Pawlik A
    Ann Acad Med Stetin; 2013; 59(2):39-42. PubMed ID: 25026748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rheumatoid arthritis: an update.
    Derk CT
    Del Med J; 2005 Feb; 77(2):59-63. PubMed ID: 15887927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The treatment of rheumatoid polyarthritis using salazosulfapyridine (Salazopyrine). A 6-month open study of 34 patients].
    Ghozlan R; Dupuis M; Schwak A; Jorro P; Lecarpentier C; Guillon C
    Rev Rhum Mal Osteoartic; 1988 Feb; 55(2):127-30. PubMed ID: 2895959
    [No Abstract]   [Full Text] [Related]  

  • 59. The use of the AIMS questionnaire in the evaluation of sulphasalazine treatment in rheumatoid arthritis.
    Pelísková Z; Trnavský K; Vácha J
    Z Rheumatol; 1987; 46(3):124-8. PubMed ID: 2442919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological and biochemical actions of sulphasalazine.
    Hoult JR
    Drugs; 1986; 32 Suppl 1():18-26. PubMed ID: 2877850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.